Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,877,000 | 11,435,000 | 9,556,000 | 6,656,000 | 7,066,000 |
| Marketable Securities | 100,000 | 155,000 | 197,000 | 344,000 | 130,000 |
| Receivables | 9,602,000 | 9,142,000 | 8,984,000 | 9,176,000 | 8,725,000 |
| Inventories | 6,286,000 | 6,269,000 | 6,421,000 | 6,307,000 | 5,829,000 |
| Other current assets | 3,742,000 | 3,459,000 | 3,040,000 | 3,456,000 | 3,358,000 |
| TOTAL | $26,607,000 | $30,460,000 | $28,198,000 | $25,939,000 | $25,108,000 |
| Non-Current Assets | |||||
| PPE Net | 10,654,000 | 10,782,000 | 10,476,000 | 10,380,000 | 9,680,000 |
| Investments And Advances | 100,000 | 98,000 | 2,153,000 | 2,161,000 | 114,000 |
| Intangibles | 67,028,000 | 54,978,000 | 54,588,000 | 54,793,000 | 52,441,000 |
| Other Non-Current Assets | 14,143,000 | 14,631,000 | 11,874,000 | 11,122,000 | 12,598,000 |
| TOTAL | $91,925,000 | $80,489,000 | $79,091,000 | $78,456,000 | $74,833,000 |
| Total Assets | $118,532,000 | $110,949,000 | $107,289,000 | $104,395,000 | $99,941,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,617,000 | 5,602,000 | 7,520,000 | 8,314,000 | 7,801,000 |
| Accounts payable and accrued liabilities | 4,322,000 | 4,456,000 | 4,555,000 | 4,506,000 | 4,261,000 |
| Other current liabilities | 17,357,000 | 14,988,000 | 16,319,000 | 15,809,000 | 16,745,000 |
| TOTAL | $31,374,000 | $27,278,000 | $32,000,000 | $31,714,000 | $31,619,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,447,000 | 27,935,000 | 22,598,000 | 22,470,000 | 21,666,000 |
| Other Non-Current Liabilities | 5,680,000 | 5,795,000 | 5,766,000 | 5,853,000 | 5,653,000 |
| TOTAL | $48,231,000 | $37,122,000 | $30,537,000 | $30,627,000 | $29,870,000 |
| Total Liabilities | $79,605,000 | $64,400,000 | $62,537,000 | $62,341,000 | $61,489,000 |
| Shareholders' Equity | |||||
| Common Shares | 736,000 | 766,000 | 766,000 | 766,000 | 766,000 |
| Retained earnings | 37,823,000 | 45,414,000 | 43,608,000 | 41,252,000 | 37,622,000 |
| Other shareholders' equity | 415,000 | 419,000 | 422,000 | 69,000 | 83,000 |
| TOTAL | $38,927,000 | $46,549,000 | $44,752,000 | $42,054,000 | $38,452,000 |
| Total Liabilities And Equity | $118,532,000 | $110,949,000 | $107,289,000 | $104,395,000 | $99,941,000 |